Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Association between systemic inflammatory markers and serum prostate-specific antigen in men without prostatic disease - the 2001-2008 National Health and Nutrition Examination Survey.

McDonald AC, Vira MA, Vidal AC, Gan W, Freedland SJ, Taioli E.

Prostate. 2014 May;74(5):561-7. doi: 10.1002/pros.22782. Epub 2014 Jan 16.

2.

Shiftwork and prostate-specific antigen in the National Health and Nutrition Examination Survey.

Flynn-Evans EE, Mucci L, Stevens RG, Lockley SW.

J Natl Cancer Inst. 2013 Sep 4;105(17):1292-7. doi: 10.1093/jnci/djt169. Epub 2013 Aug 13.

3.

Total, free, and percent free prostate-specific antigen levels among U.S. men, 2001-04.

Lacher DA, Thompson TD, Hughes JP, Saraiya M.

Adv Data. 2006 Dec 4;(379):1-12.

PMID:
17348177
4.

Histological inflammation and risk of subsequent prostate cancer among men with initially elevated serum prostate-specific antigen (PSA) concentration in the Finnish prostate cancer screening trial.

Yli-Hemminki TH, Laurila M, Auvinen A, Määttänen L, Huhtala H, Tammela TL, Kujala PM.

BJU Int. 2013 Oct;112(6):735-41. doi: 10.1111/bju.12153. Epub 2013 Jun 7.

5.

The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.

Culp S, Porter M.

BJU Int. 2009 Nov;104(10):1457-61. doi: 10.1111/j.1464-410X.2009.08646.x. Epub 2009 Jun 12.

7.

Association of urinary phytoestrogen concentrations with serum concentrations of prostate-specific antigen in the National Health and Nutrition Examination Survey.

Walser-Domjan E, Richard A, Eichholzer M, Platz EA, Linseisen J, Rohrmann S.

Nutr Cancer. 2013;65(6):813-9. doi: 10.1080/01635581.2013.801999.

8.

Serum prostate-specific antigen association with neutrophil counts: results from the National Health and Nutrition Examination Survey 2001-2010.

Kohli M, Loprinzi PD.

Int J Urol. 2014 Feb;21(2):224-5. doi: 10.1111/iju.12240. Epub 2013 Aug 1. No abstract available.

9.

Obesity and prostate cancer detection: insights from three national surveys.

Parekh N, Lin Y, Dipaola RS, Marcella S, Lu-Yao G.

Am J Med. 2010 Sep;123(9):829-35. doi: 10.1016/j.amjmed.2010.05.011.

10.

Effect of digital rectal examination on serum complexed and free prostate-specific antigen and percentage of free prostate-specific antigen.

Lechevallier E, Eghazarian C, Ortega JC, Roux F, Coulange C.

Urology. 1999 Nov;54(5):857-61.

PMID:
10565747
11.

Benign prostatic hyperplasia and prostate cancer differentiation via platelet to lymphocyte ratio.

Kaynar M, Yildirim ME, Gul M, Kilic O, Ceylan K, Goktas S.

Cancer Biomark. 2015;15(3):317-23. doi: 10.3233/CBM-150458.

PMID:
25586096
12.

Prostate-specific antigen levels in the United States: implications of various definitions for abnormal.

Welch HG, Schwartz LM, Woloshin S.

J Natl Cancer Inst. 2005 Aug 3;97(15):1132-7.

PMID:
16077071
13.

Serum folate and prostate-specific antigen in the United States.

Han YY, Song JY, Talbott EO.

Cancer Causes Control. 2013 Aug;24(8):1595-604. doi: 10.1007/s10552-013-0236-7. Epub 2013 May 24.

PMID:
23702887
14.
15.

Circulating total testosterone and PSA concentrations in a nationally representative sample of men without a diagnosis of prostate cancer.

Peskoe SB, Joshu CE, Rohrmann S, McGlynn KA, Nyante SJ, Bradwin G, Dobs AS, Kanarek N, Nelson WG, Platz EA.

Prostate. 2015 Aug 1;75(11):1167-76. doi: 10.1002/pros.22998. Epub 2015 Apr 28.

16.

Prostatic involvement in men with febrile urinary tract infection as measured by serum prostate-specific antigen and transrectal ultrasonography.

Ulleryd P, Zackrisson B, Aus G, Bergdahl S, Hugosson J, Sandberg T.

BJU Int. 1999 Sep;84(4):470-4.

PMID:
10468764
17.
19.
20.

Effect of subclinical prostatic inflammation on serum PSA levels in men with clinically undetectable prostate cancer.

Kwak C, Ku JH, Kim T, Park DW, Choi KY, Lee E, Lee SE, Lee C.

Urology. 2003 Nov;62(5):854-9.

PMID:
14624908

Supplemental Content

Support Center